Let the Best ETFs Australia editorial team choose our favourite reporting, expert analysis, research and video news then deliver it free to your ETF news feed daily.
Our markets chart above shows the price of major markets around the world, using ETFs to track them.
Xero Limited (ASX: XRO) reported its FY21 half-year result to investors showing more strong growth. Is the Xero share price a buy after this report?
Australia’s share market — or S&P/ASX 200 (ASX: XJO) and All Ordinaries (ASX: XAO) — is expected to rise Thursday morning following strong overnight gains. Here’s what you need to know…
The Australian share market and S&P/ASX 200 index is expected to open slightly higher, following the US markets overnight.
Would a shrewd ASX investor consider the BetaShares S&P 500
The Australian share market or S&P/ASX 200 (ASX: XJO) is expected to push higher when the market opens on Wednesday according to the latest SPI futures. Here’s your daily ASX ETF investor morning report.
The Australian share market and S&P/ASX 200 (ASX: XJO) is expected to open flat according to data from SPI futures. Here’s what you need to know.
The S&P/ASX 200 (INDEXASX:XJO) is tipped to slide when the market opens on Thursday. Zip Co Ltd (ASX:Z1P) and Whitehaven (ASX:WHC) shares are making headlines.
Would a shrewd ASX investor consider the iShares Global 100 AUD Hedged ETF (ASX: IHOO) and Russell Investments Australian Select Corporate Bond ETF (ASX: RCB) right about now?
With healthcare well and truly in the spotlight in 2020, let’s take a look at the iShares Global Healthcare ETF (ASX:IXJ) and its merits in a diversified portfolio.
I believe that Vanguard FTSE Asia Ex-Japan Shares Index ETF (ASX:VAE) is a really good contender to add good diversification to a portfolio.
Xero Limited (ASX: XRO) reported its FY21 half-year result to investors showing more strong growth. Is the Xero share price a buy after this report?
Australia’s share market — or S&P/ASX 200 (ASX: XJO) and All Ordinaries (ASX: XAO) — is expected to rise Thursday morning following strong overnight gains. Here’s what you need to know…
The Australian share market and S&P/ASX 200 index is expected to open slightly higher, following the US markets overnight.
Would a shrewd ASX investor consider the BetaShares S&P 500
The Australian share market or S&P/ASX 200 (ASX: XJO) is expected to push higher when the market opens on Wednesday according to the latest SPI futures. Here’s your daily ASX ETF investor morning report.
The Australian share market and S&P/ASX 200 (ASX: XJO) is expected to open flat according to data from SPI futures. Here’s what you need to know.
The S&P/ASX 200 (INDEXASX:XJO) is tipped to slide when the market opens on Thursday. Zip Co Ltd (ASX:Z1P) and Whitehaven (ASX:WHC) shares are making headlines.
Would a shrewd ASX investor consider the iShares Global 100 AUD Hedged ETF (ASX: IHOO) and Russell Investments Australian Select Corporate Bond ETF (ASX: RCB) right about now?
With healthcare well and truly in the spotlight in 2020, let’s take a look at the iShares Global Healthcare ETF (ASX:IXJ) and its merits in a diversified portfolio.
I believe that Vanguard FTSE Asia Ex-Japan Shares Index ETF (ASX:VAE) is a really good contender to add good diversification to a portfolio.
Right now, there are 200+ ETFs on the ASX. Then there are index funds. Hundreds of managed funds. LICs. REITs. And everything in between. Wouldn’t it be nice to make ONE investment and build the strong Core of your portfolio — with just one click?
Rask’s lead ETF research analyst and investing team have identified our #1 ETF for 2021 and beyond. Our analyst team has put together a full research report and a step-by-step investment guide to buying this ETF.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian-owned.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024